FAQ

Mind Medicine Australia is a registered charity working to alleviate the suffering and suicides caused by mental illness by expanding treatment options through the safe, clinical use of psychedelic-assisted therapies to treat depression, trauma, addictions and other intractable conditions.

MMA’s wholly clinical focus includes building a national ecosystem encompassing professional development for health practitioners through the world-leading Certificate in Psychedelic-Assisted Therapies (CPAT)™, patient access pathways, medicine supplies, regulatory and research advancements, clinical rollouts and widespread awareness and education. MMA made global history through their successful rescheduling applications for psilocybin and MDMA making Australia the first nation in the world to reschedule these medicines for clinical use in 2023.

Our mission is to reduce suffering by building a clinical ecosystem that includes:

• Patient access
• Awareness and knowledge building
• Professional training and education
• Research

Conventional treatments for mental illness do not work for everyone. Psychedelic-assisted therapies have shown promising results for people experiencing conditions such as PTSD, treatment-resistant depression, anxiety, addiction, OCD, and eating disorders.

Psilocybin-assisted therapy can lead to remission in 60-80% of cases of anxiety and depression[1,2], whereas current existing treatments lead to remission in a maximum of 30-35% of cases. To date, there have been 617+ current and completed trials for psychedelic therapies.

[1] Griffiths, R. R. et al. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of psychopharmacology, 30(12), 1181-1197.
[2] Ross et al. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of Psychopharmacology, 30-12:1165-1180.

Yes. As of July 1, 2023, Authorised Prescriber psychiatrists in Australia are permitted to prescribe psilocybin for treatment-resistant depression and MDMA for PTSD.

All treatments must occur in regulated clinical environments under the supervision of qualified professionals. You can find a list of Authorised Prescribers in Australia here.

Eligible patients can receive treatment through Authorised Prescriber clinics located across Australia, as well as at the Mind Medicine Australia Clinic and Centre of Excellence in Melbourne.

To date, more than 180+ patients have received treatment with support from over 50 trained psychiatrists and associated clinics.

Clinical psychedelic therapies are fundamentally different from recreational drug use. These treatments utilise pharmaceutical-grade psilocybin and MDMA administered in safe, controlled settings under the guidance of two trained therapists.

These treatments are part of a structured therapeutic process that includes preparation, dosing sessions, and integration therapy. They are strictly medical interventions and not recreational experiences.

Psychedelic-assisted therapies have been shown to be safe when used in clinical settings. Studies report a low risk of addiction, no toxic effects at therapeutic doses, and strong safety outcomes when administered by trained professionals.

Over 300+ clinical studies worldwide support the safety and potential benefits of these treatments.

A standard treatment program typically includes several preparation sessions, one to three supervised dosing sessions, and follow-up integration therapy to support long-term benefits.

The exact treatment plan is tailored to each individual based on their diagnosis and specific needs. The duration is usually from three to four months in total.

Learn more about the process of psychedelic-assisted therapies here.

The cost of treatment varies depending on the provider, the number of sessions required, and the patient’s condition.

Financial assistance options include our Patient Support Fund (offering up to $10,500 for eligible patients), as well as coverage through NDIS, the Department of Veterans’ Affairs, Medicare rebates, Medibank and other health insurers, private payment, and early access to superannuation.

You can learn more about funding options here.

The world-leading Certificate in Psychedelic-Assisted Therapies (CPAT)™ is a part online and part face-to-face professional training program that provides registered healthcare professionals with the knowledge and skills to safely and effectively administer psychedelic-assisted therapies (PAT) in clinical settings. More than 600+ psychiatrists and other clinicians have completed this program. Many rate it as the best professional training they have completed. Please see testimonials here.

This program is both for prescribing psychiatrists, as well as other mental health professionals who will be delivering the treatment as part of a multidisciplinary team. Eligible professions include psychiatrists, medical practitioners, psychologists, registered psychotherapists and counsellors, nurses, social workers, occupational therapists, registered allied health professionals, addiction specialists, pharmacists, spiritual carers, and selected complementary medicine practitioners.

The training is delivered by a world-class Faculty made up of global leaders in the field. It teaches best practice for the delivery of PAT, with a focus on psilocybin, MDMA and ketamine-assisted therapy. These are the three psychedelic medicines with regulatory approval in Australia.

For more information or to apply, visit the program website.

1. Contribute to the Mind Medicine Australia Patient Support Fund (PSF) to directly subsidise the treatment costs for those in need.
2. Donate to Mind Medicine Australia to support Psychedelic Research, Public Education and Therapist Training
3. Spread the word to your friends, colleagues and networks about the potential of Psychedelic-Assisted Therapies.
4. Submit your application for our Certificate in Psychedelic-Assisted Therapies (CPAT)™.
5. Complete the Fundamentals in PAT Online course.
6. Register for and attend our Global Webinar Series.
7. Keep up to date with the latest news about Psychedelic Medicine by accessing information from Mind Medicine’s website and subscribing to our regular newsletter. Click HERE and scroll down to subscribe.
8. See the progress we have made in Mind Medicine Australia’s First Six Years.
9. Subscribe and listen to the Mind Medicine Australia Podcast series.
10. Purchase the first Australian book of true healing stories, which reinforces the life-changing and life-saving impact of psychedelic-assisted therapies for a range of mental illnesses and addictions.
11. Purchase our range of unique merchandise and Support our Product Partners.
12. Share our 2-minute Animation about psychedelic-assisted therapies far and wide!
13. Volunteer to work with Mind Medicine Australia. We are a small organisation doing big things. If you feel you have the skills and time to lend us a hand…please get in touch.